APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA & DHA Omega-3

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global EPA & DHA Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchEPA & DHA Omega-3 Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA & DHA Omega-3 Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal EPA & DHA Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA & DHA Omega-3 Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA & DHA Omega-3 Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global EPA & DHA Omega-3 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EPA & DHA Omega-3 include Shandong Yuwang Pharmaceutical, Xinzhou, TASA, Solutex, Skuny, Sinomega, Polaris, Orkla Health and Omega Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA & DHA Omega-3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA & DHA Omega-3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA & DHA Omega-3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA & DHA Omega-3 market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA & DHA Omega-3 Segment by Company

Shandong Yuwang Pharmaceutical

Xinzhou

TASA

Solutex

Skuny

Sinomega

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

Marine Ingredients

LYSI

Kinomega

KD Pharma

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

DSM

Croda

Bioprocess Algae

BASF

Auqi

Anti-Cancer

EPA & DHA Omega-3 Segment by Type

Marine Animals Source Omega-3

Marine Plant Source Omega-3

EPA & DHA Omega-3 Segment by Application

Pet Foods

Fortified Food and Beverage

Dietary Supplements

Pharmaceuticals

Infant Formula

Others

EPA & DHA Omega-3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA Omega-3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA & DHA Omega-3 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EPA & DHA Omega-3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of EPA & DHA Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of EPA & DHA Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. EPA & DHA Omega-3 Industry Trends Table 2. EPA & DHA Omega-3 Industry Drivers Table 3. EPA & DHA Omega-3 Industry Opportunities and Challenges Table 4. EPA & DHA Omega-3 Industry Restraints Table 5. Global EPA & DHA Omega-3 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global EPA & DHA Omega-3 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global EPA & DHA Omega-3 Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global EPA & DHA Omega-3 Sales Market Share by Manufacturers Table 9. Global EPA & DHA Omega-3 Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global EPA & DHA Omega-3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global EPA & DHA Omega-3 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global EPA & DHA Omega-3 Manufacturers, Product Type & Application Table 13. Global EPA & DHA Omega-3 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA & DHA Omega-3 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Marine Animals Source Omega-3 Table 17. Major Manufacturers of Marine Plant Source Omega-3 Table 18. Global EPA & DHA Omega-3 Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 19. Global EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 20. Global EPA & DHA Omega-3 Sales by Type (2027-2032) & (K Tons) Table 21. Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2026) Table 22. Global EPA & DHA Omega-3 Sales Market Share by Type (2027-2032) Table 23. Global EPA & DHA Omega-3 Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 24. Global EPA & DHA Omega-3 Revenue by Type (2021-2026) & (K Tons) Table 25. Global EPA & DHA Omega-3 Revenue by Type (2027-2032) & (K Tons) Table 26. Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2026) Table 27. Global EPA & DHA Omega-3 Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pet Foods Table 29. Major Manufacturers of Fortified Food and Beverage Table 30. Major Manufacturers of Dietary Supplements Table 31. Major Manufacturers of Pharmaceuticals Table 32. Major Manufacturers of Infant Formula Table 33. Major Manufacturers of Others Table 34. Global EPA & DHA Omega-3 Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 35. Global EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 36. Global EPA & DHA Omega-3 Sales by Application (2027-2032) & (K Tons) Table 37. Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2026) Table 38. Global EPA & DHA Omega-3 Sales Market Share by Application (2027-2032) Table 39. Global EPA & DHA Omega-3 Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 40. Global EPA & DHA Omega-3 Revenue by Application (2021-2026) & (K Tons) Table 41. Global EPA & DHA Omega-3 Revenue by Application (2027-2032) & (K Tons) Table 42. Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2026) Table 43. Global EPA & DHA Omega-3 Revenue Market Share by Application (2027-2032) Table 44. Global EPA & DHA Omega-3 Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 45. Global EPA & DHA Omega-3 Sales by Region (2021-2026) & (K Tons) Table 46. Global EPA & DHA Omega-3 Sales Market Share by Region (2021-2026) Table 47. Global EPA & DHA Omega-3 Sales Forecasted by Region (2027-2032) & (K Tons) Table 48. Global EPA & DHA Omega-3 Sales Forecasted Market Share by Region (2027-2032) Table 49. North America EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 50. North America EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 51. North America EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 52. Europe EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 53. Europe EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 54. Europe EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 55. Asia Pacific EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Asia Pacific EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 57. Asia Pacific EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 58. South America, Middle East and Africa EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 59. South America, Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 60. South America, Middle East and Africa EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 61. Global EPA & DHA Omega-3 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global EPA & DHA Omega-3 Revenue by Region (2021-2026) & (US$ Million) Table 63. Global EPA & DHA Omega-3 Revenue by Region (2027-2032) & (US$ Million) Table 64. Global EPA & DHA Omega-3 Revenue Market Share by Region (2021-2026) Table 65. Global EPA & DHA Omega-3 Revenue Market Share by Region (2027-2032) Table 66. Shandong Yuwang Pharmaceutical Company Information Table 67. Shandong Yuwang Pharmaceutical Business Overview Table 68. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio Table 70. Shandong Yuwang Pharmaceutical Recent Development Table 71. Xinzhou Company Information Table 72. Xinzhou Business Overview Table 73. Xinzhou EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Xinzhou EPA & DHA Omega-3 Product Portfolio Table 75. Xinzhou Recent Development Table 76. TASA Company Information Table 77. TASA Business Overview Table 78. TASA EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. TASA EPA & DHA Omega-3 Product Portfolio Table 80. TASA Recent Development Table 81. Solutex Company Information Table 82. Solutex Business Overview Table 83. Solutex EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Solutex EPA & DHA Omega-3 Product Portfolio Table 85. Solutex Recent Development Table 86. Skuny Company Information Table 87. Skuny Business Overview Table 88. Skuny EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Skuny EPA & DHA Omega-3 Product Portfolio Table 90. Skuny Recent Development Table 91. Sinomega Company Information Table 92. Sinomega Business Overview Table 93. Sinomega EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Sinomega EPA & DHA Omega-3 Product Portfolio Table 95. Sinomega Recent Development Table 96. Polaris Company Information Table 97. Polaris Business Overview Table 98. Polaris EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Polaris EPA & DHA Omega-3 Product Portfolio Table 100. Polaris Recent Development Table 101. Orkla Health Company Information Table 102. Orkla Health Business Overview Table 103. Orkla Health EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Orkla Health EPA & DHA Omega-3 Product Portfolio Table 105. Orkla Health Recent Development Table 106. Omega Protein Company Information Table 107. Omega Protein Business Overview Table 108. Omega Protein EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Omega Protein EPA & DHA Omega-3 Product Portfolio Table 110. Omega Protein Recent Development Table 111. OLVEA Fish Oils Company Information Table 112. OLVEA Fish Oils Business Overview Table 113. OLVEA Fish Oils EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio Table 115. OLVEA Fish Oils Recent Development Table 116. Nippon Suisan Kaisha Company Information Table 117. Nippon Suisan Kaisha Business Overview Table 118. Nippon Suisan Kaisha EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio Table 120. Nippon Suisan Kaisha Recent Development Table 121. Maruha Nichiro Foods Company Information Table 122. Maruha Nichiro Foods Business Overview Table 123. Maruha Nichiro Foods EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio Table 125. Maruha Nichiro Foods Recent Development Table 126. Marine Ingredients Company Information Table 127. Marine Ingredients Business Overview Table 128. Marine Ingredients EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Marine Ingredients EPA & DHA Omega-3 Product Portfolio Table 130. Marine Ingredients Recent Development Table 131. LYSI Company Information Table 132. LYSI Business Overview Table 133. LYSI EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. LYSI EPA & DHA Omega-3 Product Portfolio Table 135. LYSI Recent Development Table 136. Kinomega Company Information Table 137. Kinomega Business Overview Table 138. Kinomega EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Kinomega EPA & DHA Omega-3 Product Portfolio Table 140. Kinomega Recent Development Table 141. KD Pharma Company Information Table 142. KD Pharma Business Overview Table 143. KD Pharma EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. KD Pharma EPA & DHA Omega-3 Product Portfolio Table 145. KD Pharma Recent Development Table 146. Hofseth BioCare Company Information Table 147. Hofseth BioCare Business Overview Table 148. Hofseth BioCare EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Hofseth BioCare EPA & DHA Omega-3 Product Portfolio Table 150. Hofseth BioCare Recent Development Table 151. Golden Omega Company Information Table 152. Golden Omega Business Overview Table 153. Golden Omega EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Golden Omega EPA & DHA Omega-3 Product Portfolio Table 155. Golden Omega Recent Development Table 156. GC Rieber Company Information Table 157. GC Rieber Business Overview Table 158. GC Rieber EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. GC Rieber EPA & DHA Omega-3 Product Portfolio Table 160. GC Rieber Recent Development Table 161. EPAX Company Information Table 162. EPAX Business Overview Table 163. EPAX EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. EPAX EPA & DHA Omega-3 Product Portfolio Table 165. EPAX Recent Development Table 166. DSM Company Information Table 167. DSM Business Overview Table 168. DSM EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. DSM EPA & DHA Omega-3 Product Portfolio Table 170. DSM Recent Development Table 171. Croda Company Information Table 172. Croda Business Overview Table 173. Croda EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Croda EPA & DHA Omega-3 Product Portfolio Table 175. Croda Recent Development Table 176. Bioprocess Algae Company Information Table 177. Bioprocess Algae Business Overview Table 178. Bioprocess Algae EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Bioprocess Algae EPA & DHA Omega-3 Product Portfolio Table 180. Bioprocess Algae Recent Development Table 181. BASF Company Information Table 182. BASF Business Overview Table 183. BASF EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. BASF EPA & DHA Omega-3 Product Portfolio Table 185. BASF Recent Development Table 186. Auqi Company Information Table 187. Auqi Business Overview Table 188. Auqi EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. Auqi EPA & DHA Omega-3 Product Portfolio Table 190. Auqi Recent Development Table 191. Anti-Cancer Company Information Table 192. Anti-Cancer Business Overview Table 193. Anti-Cancer EPA & DHA Omega-3 Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. Anti-Cancer EPA & DHA Omega-3 Product Portfolio Table 195. Anti-Cancer Recent Development Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. EPA & DHA Omega-3 Distributors List Table 199. EPA & DHA Omega-3 Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. EPA & DHA Omega-3 Product Image Figure 2. Global EPA & DHA Omega-3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA & DHA Omega-3 Market Size (2021-2032) & (US$ Million) Figure 4. Global EPA & DHA Omega-3 Sales (2021-2032) & (K Tons) Figure 5. Global EPA & DHA Omega-3 Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 EPA & DHA Omega-3 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Marine Animals Source Omega-3 Image Figure 9. Marine Plant Source Omega-3 Image Figure 10. Global EPA & DHA Omega-3 Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 11. Global EPA & DHA Omega-3 Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2032) Figure 13. Global EPA & DHA Omega-3 Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 14. Global EPA & DHA Omega-3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2032) Figure 16. Pet Foods Image Figure 17. Fortified Food and Beverage Image Figure 18. Dietary Supplements Image Figure 19. Pharmaceuticals Image Figure 20. Infant Formula Image Figure 21. Others Image Figure 22. Global EPA & DHA Omega-3 Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 23. Global EPA & DHA Omega-3 Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2032) Figure 25. Global EPA & DHA Omega-3 Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 26. Global EPA & DHA Omega-3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2032) Figure 28. North America EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. North America EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 30. U.S. EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Canada EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Mexico EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 33. Europe EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. Europe EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 35. Germany EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. France EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. U.K. EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Italy EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Netherlands EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. Asia Pacific EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Asia Pacific EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 42. China EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Japan EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. South Korea EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Southeast Asia EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. India EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. Australia EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. South America, Middle East and Africa EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South America, Middle East and Africa EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 50. Brazil EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. South Africa EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Saudi Arabia EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. Turkey EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Argentina EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. UAE EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Egypt EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 57. Chile EPA & DHA Omega-3 Sales and Growth Rate (2021-2032) & (K Tons) Figure 58. Global EPA & DHA Omega-3 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global EPA & DHA Omega-3 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America EPA & DHA Omega-3 Revenue (2021-2032) & (US$ Million) Figure 61. North America EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe EPA & DHA Omega-3 Revenue (2021-2032) & (US$ Million) Figure 63. Europe EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific EPA & DHA Omega-3 Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa EPA & DHA Omega-3 Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. EPA & DHA Omega-3 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. EPA & DHA Omega-3 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Marine Animals Source Omega-3
  • Marine Plant Source Omega-3
Applications
  • Pet Foods
  • Fortified Food and Beverage
  • Dietary Supplements
  • Pharmaceuticals
  • Infant Formula
  • Others
Companies covered
  • Shandong Yuwang Pharmaceutical
  • Xinzhou
  • TASA
  • Solutex
  • Skuny
  • Sinomega
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • Marine Ingredients
  • LYSI
  • Kinomega
  • KD Pharma
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • DSM
  • Croda
  • Bioprocess Algae
  • BASF
  • Auqi
  • Anti-Cancer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global EPA & DHA Omega-3 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global EPA & DHA Omega-3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global EPA & DHA Omega-3 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global EPA & DHA Omega-3 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global EPA & DHA Omega-3 Market Dynamics
  1. 2.1 EPA & DHA Omega-3 Industry Trends
  2. 2.2 EPA & DHA Omega-3 Industry Drivers
  3. 2.3 EPA & DHA Omega-3 Industry Opportunities and Challenges
  4. 2.4 EPA & DHA Omega-3 Industry Restraints
3 EPA & DHA Omega-3 Market by Manufacturers
  1. 3.1 Global EPA & DHA Omega-3 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global EPA & DHA Omega-3 Sales by Manufacturers (2021-2026)
  3. 3.3 Global EPA & DHA Omega-3 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global EPA & DHA Omega-3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EPA & DHA Omega-3 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global EPA & DHA Omega-3 Manufacturers, Product Type & Application
  7. 3.7 Global EPA & DHA Omega-3 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EPA & DHA Omega-3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EPA & DHA Omega-3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EPA & DHA Omega-3 Tier 1, Tier 2, and Tier 3
4 EPA & DHA Omega-3 Market by Type
  1. 4.1 EPA & DHA Omega-3 Type Introduction
  2. 4.1.1 Marine Animals Source Omega-3
  3. 4.1.2 Marine Plant Source Omega-3
  4. 4.2 Global EPA & DHA Omega-3 Sales by Type
  5. 4.2.1 Global EPA & DHA Omega-3 Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EPA & DHA Omega-3 Sales by Type (2021-2032)
  7. 4.2.3 Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2032)
  8. 4.3 Global EPA & DHA Omega-3 Revenue by Type
  9. 4.3.1 Global EPA & DHA Omega-3 Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global EPA & DHA Omega-3 Revenue by Type (2021-2032)
  11. 4.3.3 Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2032)
5 EPA & DHA Omega-3 Market by Application
  1. 5.1 EPA & DHA Omega-3 Application Introduction
  2. 5.1.1 Pet Foods
  3. 5.1.2 Fortified Food and Beverage
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Pharmaceuticals
  6. 5.1.5 Infant Formula
  7. 5.1.6 Others
  8. 5.2 Global EPA & DHA Omega-3 Sales by Application
  9. 5.2.1 Global EPA & DHA Omega-3 Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global EPA & DHA Omega-3 Sales by Application (2021-2032)
  11. 5.2.3 Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2032)
  12. 5.3 Global EPA & DHA Omega-3 Revenue by Application
  13. 5.3.1 Global EPA & DHA Omega-3 Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global EPA & DHA Omega-3 Revenue by Application (2021-2032)
  15. 5.3.3 Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2032)
6 Global EPA & DHA Omega-3 Sales by Region
  1. 6.1 Global EPA & DHA Omega-3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA & DHA Omega-3 Sales by Region (2021-2032)
  3. 6.2.1 Global EPA & DHA Omega-3 Sales by Region (2021-2026)
  4. 6.2.2 Global EPA & DHA Omega-3 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America EPA & DHA Omega-3 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe EPA & DHA Omega-3 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific EPA & DHA Omega-3 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa EPA & DHA Omega-3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global EPA & DHA Omega-3 Revenue by Region
  1. 7.1 Global EPA & DHA Omega-3 Revenue by Region
  2. 7.1.1 Global EPA & DHA Omega-3 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global EPA & DHA Omega-3 Revenue by Region (2021-2026)
  4. 7.1.3 Global EPA & DHA Omega-3 Revenue by Region (2027-2032)
  5. 7.1.4 Global EPA & DHA Omega-3 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America EPA & DHA Omega-3 Revenue (2021-2032)
  8. 7.2.2 North America EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe EPA & DHA Omega-3 Revenue (2021-2032)
  11. 7.3.2 Europe EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific EPA & DHA Omega-3 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa EPA & DHA Omega-3 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa EPA & DHA Omega-3 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Yuwang Pharmaceutical
  2. 8.1.1 Shandong Yuwang Pharmaceutical Company Information
  3. 8.1.2 Shandong Yuwang Pharmaceutical Business Overview
  4. 8.1.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio
  6. 8.1.5 Shandong Yuwang Pharmaceutical Recent Developments
  7. 8.2 Xinzhou
  8. 8.2.1 Xinzhou Company Information
  9. 8.2.2 Xinzhou Business Overview
  10. 8.2.3 Xinzhou EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xinzhou EPA & DHA Omega-3 Product Portfolio
  12. 8.2.5 Xinzhou Recent Developments
  13. 8.3 TASA
  14. 8.3.1 TASA Company Information
  15. 8.3.2 TASA Business Overview
  16. 8.3.3 TASA EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TASA EPA & DHA Omega-3 Product Portfolio
  18. 8.3.5 TASA Recent Developments
  19. 8.4 Solutex
  20. 8.4.1 Solutex Company Information
  21. 8.4.2 Solutex Business Overview
  22. 8.4.3 Solutex EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Solutex EPA & DHA Omega-3 Product Portfolio
  24. 8.4.5 Solutex Recent Developments
  25. 8.5 Skuny
  26. 8.5.1 Skuny Company Information
  27. 8.5.2 Skuny Business Overview
  28. 8.5.3 Skuny EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Skuny EPA & DHA Omega-3 Product Portfolio
  30. 8.5.5 Skuny Recent Developments
  31. 8.6 Sinomega
  32. 8.6.1 Sinomega Company Information
  33. 8.6.2 Sinomega Business Overview
  34. 8.6.3 Sinomega EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinomega EPA & DHA Omega-3 Product Portfolio
  36. 8.6.5 Sinomega Recent Developments
  37. 8.7 Polaris
  38. 8.7.1 Polaris Company Information
  39. 8.7.2 Polaris Business Overview
  40. 8.7.3 Polaris EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Polaris EPA & DHA Omega-3 Product Portfolio
  42. 8.7.5 Polaris Recent Developments
  43. 8.8 Orkla Health
  44. 8.8.1 Orkla Health Company Information
  45. 8.8.2 Orkla Health Business Overview
  46. 8.8.3 Orkla Health EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Orkla Health EPA & DHA Omega-3 Product Portfolio
  48. 8.8.5 Orkla Health Recent Developments
  49. 8.9 Omega Protein
  50. 8.9.1 Omega Protein Company Information
  51. 8.9.2 Omega Protein Business Overview
  52. 8.9.3 Omega Protein EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Omega Protein EPA & DHA Omega-3 Product Portfolio
  54. 8.9.5 Omega Protein Recent Developments
  55. 8.10 OLVEA Fish Oils
  56. 8.10.1 OLVEA Fish Oils Company Information
  57. 8.10.2 OLVEA Fish Oils Business Overview
  58. 8.10.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio
  60. 8.10.5 OLVEA Fish Oils Recent Developments
  61. 8.11 Nippon Suisan Kaisha
  62. 8.11.1 Nippon Suisan Kaisha Company Information
  63. 8.11.2 Nippon Suisan Kaisha Business Overview
  64. 8.11.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio
  66. 8.11.5 Nippon Suisan Kaisha Recent Developments
  67. 8.12 Maruha Nichiro Foods
  68. 8.12.1 Maruha Nichiro Foods Company Information
  69. 8.12.2 Maruha Nichiro Foods Business Overview
  70. 8.12.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio
  72. 8.12.5 Maruha Nichiro Foods Recent Developments
  73. 8.13 Marine Ingredients
  74. 8.13.1 Marine Ingredients Company Information
  75. 8.13.2 Marine Ingredients Business Overview
  76. 8.13.3 Marine Ingredients EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Marine Ingredients EPA & DHA Omega-3 Product Portfolio
  78. 8.13.5 Marine Ingredients Recent Developments
  79. 8.14 LYSI
  80. 8.14.1 LYSI Company Information
  81. 8.14.2 LYSI Business Overview
  82. 8.14.3 LYSI EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LYSI EPA & DHA Omega-3 Product Portfolio
  84. 8.14.5 LYSI Recent Developments
  85. 8.15 Kinomega
  86. 8.15.1 Kinomega Company Information
  87. 8.15.2 Kinomega Business Overview
  88. 8.15.3 Kinomega EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kinomega EPA & DHA Omega-3 Product Portfolio
  90. 8.15.5 Kinomega Recent Developments
  91. 8.16 KD Pharma
  92. 8.16.1 KD Pharma Company Information
  93. 8.16.2 KD Pharma Business Overview
  94. 8.16.3 KD Pharma EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 KD Pharma EPA & DHA Omega-3 Product Portfolio
  96. 8.16.5 KD Pharma Recent Developments
  97. 8.17 Hofseth BioCare
  98. 8.17.1 Hofseth BioCare Company Information
  99. 8.17.2 Hofseth BioCare Business Overview
  100. 8.17.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hofseth BioCare EPA & DHA Omega-3 Product Portfolio
  102. 8.17.5 Hofseth BioCare Recent Developments
  103. 8.18 Golden Omega
  104. 8.18.1 Golden Omega Company Information
  105. 8.18.2 Golden Omega Business Overview
  106. 8.18.3 Golden Omega EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Golden Omega EPA & DHA Omega-3 Product Portfolio
  108. 8.18.5 Golden Omega Recent Developments
  109. 8.19 GC Rieber
  110. 8.19.1 GC Rieber Company Information
  111. 8.19.2 GC Rieber Business Overview
  112. 8.19.3 GC Rieber EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 GC Rieber EPA & DHA Omega-3 Product Portfolio
  114. 8.19.5 GC Rieber Recent Developments
  115. 8.20 EPAX
  116. 8.20.1 EPAX Company Information
  117. 8.20.2 EPAX Business Overview
  118. 8.20.3 EPAX EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 EPAX EPA & DHA Omega-3 Product Portfolio
  120. 8.20.5 EPAX Recent Developments
  121. 8.21 DSM
  122. 8.21.1 DSM Company Information
  123. 8.21.2 DSM Business Overview
  124. 8.21.3 DSM EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 DSM EPA & DHA Omega-3 Product Portfolio
  126. 8.21.5 DSM Recent Developments
  127. 8.22 Croda
  128. 8.22.1 Croda Company Information
  129. 8.22.2 Croda Business Overview
  130. 8.22.3 Croda EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Croda EPA & DHA Omega-3 Product Portfolio
  132. 8.22.5 Croda Recent Developments
  133. 8.23 Bioprocess Algae
  134. 8.23.1 Bioprocess Algae Company Information
  135. 8.23.2 Bioprocess Algae Business Overview
  136. 8.23.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Bioprocess Algae EPA & DHA Omega-3 Product Portfolio
  138. 8.23.5 Bioprocess Algae Recent Developments
  139. 8.24 BASF
  140. 8.24.1 BASF Company Information
  141. 8.24.2 BASF Business Overview
  142. 8.24.3 BASF EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BASF EPA & DHA Omega-3 Product Portfolio
  144. 8.24.5 BASF Recent Developments
  145. 8.25 Auqi
  146. 8.25.1 Auqi Company Information
  147. 8.25.2 Auqi Business Overview
  148. 8.25.3 Auqi EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Auqi EPA & DHA Omega-3 Product Portfolio
  150. 8.25.5 Auqi Recent Developments
  151. 8.26 Anti-Cancer
  152. 8.26.1 Anti-Cancer Company Information
  153. 8.26.2 Anti-Cancer Business Overview
  154. 8.26.3 Anti-Cancer EPA & DHA Omega-3 Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Anti-Cancer EPA & DHA Omega-3 Product Portfolio
  156. 8.26.5 Anti-Cancer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA & DHA Omega-3 Value Chain Analysis
  2. 9.1.1 EPA & DHA Omega-3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA & DHA Omega-3 Production Mode & Process
  6. 9.2 EPA & DHA Omega-3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA & DHA Omega-3 Distributors
  9. 9.2.3 EPA & DHA Omega-3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst